News

Nick Groombridge and Steve Baughman Recognized as IAM Global Leaders

December 1, 2023—We are pleased to announce that founding partners Nick Groombridge and Steve Baughman were recognized in IAM’s 2024 Global Leaders Guide, which identifies leading practitioners in the patent field. Nick Groombridge is one of the nation’s leading trial lawyers, focusing exclusively on intellectual property litigation. Over the past 35 years, Nick has served …

Read more

Maxwell “Mac” Fox Moderates IAM IPBC Asia Panel on Patent Litigation and PTAB Developments

Tokyo-based partner Maxwell “Mac” Fox moderated a panel at IAM IPBC Asia on recent patent litigation and PTAB developments in the United States on November 30, 2023. The event brought together the region’s most senior thought-leaders and decision makers involved in global IP issues. The panelists discussed recent developments in patent litigation at the U.S. …

Read more

Founding Partners Nick Groombridge and Jennifer Wu Discuss Starting an Elite IP Firm Away from “Big Law” with Managing IP

Managing IP featured founding partners Nick Groombridge and Jennifer Wu in an article Finding a voice: IP boutique partners reflect on quitting ‘big law’.  Nick and Jennifer spoke about the challenges of starting Groombridge, Wu, Baughman & Stone, working at their own IP boutique and their hopes for their first year. Nick talked about his desire to …

Read more

Firm Secures Significant PTAB Win for Novo Nordisk’s Blockbuster Diabetes and Obesity Treatment Drug

October 2, 2023 – Groombridge, Wu, Baughman & Stone successfully defended Novo Nordisk before the Patent Trial and Appeal Board against Mylan Pharmaceuticals in inter partes review (IPR) proceedings seeking to invalidate two Novo patents relating to its blockbuster semaglutide family of drugs, including Ozempic®, Wegovy®, and Rybelsus® (U.S. Patents Nos. 8,536,122 and 8,129,343).  The …

Read more

Firm Wins a Major Victory on Behalf of Genentech

Groombridge, Wu, Baughman & Stone LLP won a major victory on behalf of Genentech in patent litigation brought by Baxalta, Inc. and Baxalta GmbH (now subsidiaries of Takeda Pharmaceuticals) concerning Genentech’s breakthrough Hemophilia A treatment, HEMLIBRA® (emicizumab-kxwh), which has transformed the lives of thousands of patients.  The U.S. District Court for the District of Delaware …

Read more

Groombridge, Wu, Baughman & Stone LLP、東京丸の内に初の海外拠点をオープン

Groombridge, Wu, Baughman & Stone LLP (GWBS) はこの度東京に新オフィスを開設しました。米国における知的財産関連の案件 (ライセンス、訴訟、知財戦略に関するカウンセリング等) につき、東京在住の外国法事務弁護士マックスウェル (マック)・フォックスが日本のクライアントを全面的にサポートします。東京オフィスは9か月前に開設したGWBSのニューヨーク、ワシントンDCオフィスに次ぐ3番目の拠点となります。 Groombridge, Wu, Baughman & Stone LLPが東京オフィスを設立 – グローバル展開に向けた初の海外進出 | PR TIMES

Firm Opens First Overseas Office in Marunouchi, Tokyo

Groombridge, Wu, Baughman & Stone LLP proudly announces the opening of its newest office, in Tokyo.  The office will represent Japan-based clients in intellectual property disputes in the United States, and is led by prominent Japan-based U.S. patent litigator Maxwell (“Mac”) Fox. This is the third office for our patent litigation firm, which launched a little more than nine …

Read more